Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Goodwill & Intangibles (2024 - 2025)

Historic Goodwill & Intangibles for Century Therapeutics (IPSC) over the last 2 years, with Q3 2025 value amounting to $34.2 million.

  • Century Therapeutics' Goodwill & Intangibles fell 1123.11% to $34.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.2 million, marking a year-over-year decrease of 1123.11%. This contributed to the annual value of $34.2 million for FY2024, which is N/A changed from last year.
  • Century Therapeutics' Goodwill & Intangibles amounted to $34.2 million in Q3 2025, which was down 1123.11% from $34.2 million recorded in Q2 2025.
  • Century Therapeutics' 5-year Goodwill & Intangibles high stood at $38.5 million for Q3 2024, and its period low was $34.2 million during Q4 2024.